Chapter title |
Synthesis of Modified mRNA for Myocardial Delivery.
|
---|---|
Chapter number | 8 |
Book title |
Cardiac Gene Therapy
|
Published in |
Methods in molecular biology, January 2017
|
DOI | 10.1007/978-1-4939-6588-5_8 |
Pubmed ID | |
Book ISBNs |
978-1-4939-6586-1, 978-1-4939-6588-5
|
Authors |
Jason Kondrat, Nishat Sultana, Lior Zangi Ph.D., Lior Zangi |
Editors |
Kiyotake Ishikawa |
Abstract |
Cardiac gene therapy shows tremendous promise in combating the growing problem of heart disease. Modified mRNA (modRNA) is a novel gene delivery system used in vitro or in vivo to achieve transient expression of therapeutic proteins in a heterogeneous population of cells. Incorporation of specific modified nucleosides enables modRNA to be translated efficiently without triggering antiviral and innate immune responses. ModRNA has been shown to be effective at delivering short-term robust gene expression to the heart and its use in the field of cardiac gene therapy is expanding. Here, we describe a stepwise protocol for the synthesis of modRNA for in vivo myocardial delivery. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 15 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 20% |
Other | 2 | 13% |
Professor > Associate Professor | 2 | 13% |
Student > Master | 2 | 13% |
Lecturer | 1 | 7% |
Other | 3 | 20% |
Unknown | 2 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 27% |
Biochemistry, Genetics and Molecular Biology | 3 | 20% |
Agricultural and Biological Sciences | 3 | 20% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 7% |
Engineering | 1 | 7% |
Other | 0 | 0% |
Unknown | 3 | 20% |